Literature DB >> 10486345

Long term outcome of liver transplantation for viral hepatitis: is there a need to re-evaluate patient selection?

D Mutimer1.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10486345      PMCID: PMC1727668          DOI: 10.1136/gut.45.4.475

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  24 in total

1.  Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

Authors:  T Bizollon; U Palazzo; C Ducerf; M Chevallier; M Elliott; J Baulieux; M Pouyet; C Trepo
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

2.  Retransplantation for recurrent hepatitis C.

Authors:  P A Sheiner; L K Schluger; S Emre; S N Thung; J Y Lau; S R Guy; M E Schwartz; C M Miller
Journal:  Liver Transpl Surg       Date:  1997-03

Review 3.  Liver transplantation for hepatitis B: the con aspect.

Authors:  R H Wiesner; R A Krom
Journal:  Liver Transpl Surg       Date:  1995-07

4.  Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia.

Authors:  S Zhou; N A Terrault; L Ferrell; J A Hahn; J Y Lau; P Simmonds; J P Roberts; J R Lake; N L Ascher; T L Wright
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

5.  Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation.

Authors:  L K Schluger; P A Sheiner; S N Thung; J Y Lau; A Min; D C Wolf; I Fiel; D Zhang; M A Gerber; C M Miller; H C Bodenheimer
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

6.  Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis.

Authors:  L Grellier; D Mutimer; M Ahmed; D Brown; A K Burroughs; K Rolles; P McMaster; P Beranek; F Kennedy; H Kibbler; P McPhillips; E Elias; G Dusheiko
Journal:  Lancet       Date:  1996-11-02       Impact factor: 79.321

7.  Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.

Authors:  G A Tipples; M M Ma; K P Fischer; V G Bain; N M Kneteman; D L Tyrrell
Journal:  Hepatology       Date:  1996-09       Impact factor: 17.425

8.  Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.

Authors:  M M Bartholomew; R W Jansen; L J Jeffers; K R Reddy; L C Johnson; H Bunzendahl; L D Condreay; A G Tzakis; E R Schiff; N A Brown
Journal:  Lancet       Date:  1997-01-04       Impact factor: 79.321

9.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

Authors:  G Fattovich; G Giustina; F Degos; F Tremolada; G Diodati; P Almasio; F Nevens; A Solinas; D Mura; J T Brouwer; H Thomas; C Njapoum; C Casarin; P Bonetti; P Fuschi; J Basho; A Tocco; A Bhalla; R Galassini; F Noventa; S W Schalm; G Realdi
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

10.  Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.

Authors:  C Féray; M Gigou; D Samuel; V Paradis; S Mishiro; G Maertens; M Reynés; H Okamoto; H Bismuth; C Bréchot
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

View more
  1 in total

1.  Current status of liver transplantation.

Authors:  Deirdre Kelly; Anupam Sibal
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.